Clinical Trial Update: Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating procalcitonin as a marker to guide antibiotic therapy in patients with lower respiratory tract infections, including pneumonia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Exacerbation of Chronic Obstructive Pulmonary Disease
• Pneumonia

Snippet

Sponsor: Holbaek Sygehus | Conditions: Pneumonia, Acute Exacerbation of Chronic Obstructive Airways Disease | Phase 4 | Status: UNKNOWN